Ritu Roy
- Ophthalmology top 0.5%
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 14
- Oncology top 2%
- Cancer Cells and Metastasis 5
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 11
- RNA modifications and cancer 6
- Immunology top 10%
-
- Glioma Diagnosis and Treatment 9
- Genomic variations and chromosomal abnormalities 6
-
- Acute Lymphoblastic Leukemia research 7
-
- Cancer-related cognitive impairment studies 5
- Co-authors
- Boris C. BastianKlaus J. BusamKlaus GriewankMichael R. SpeicherMert SozenMichelle B. CrosbyIgor DolgalevCatherine D. Van Raamsdonk
- Cited by
- OphthalmologyCancer ResearchOncology
- Journals
- Cancer Research (4 papers)Clinical Cancer Research (3 papers)Supportive Care in Cancer (3 papers)
- Partner nations
- United StatesSouth KoreaAustralia
In The Last Decade
Ritu Roy
64 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Ophthalmology 699
- Cancer Research 665
- Oncology 1.1k
- Molecular Biology 1.4k
- Immunology 405
Countries citing papers authored by Ritu Roy
This map shows the geographic impact of Ritu Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Roy more than expected).
Fields of papers citing papers by Ritu Roy
This network shows the impact of papers produced by Ritu Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Roy. The network helps show where Ritu Roy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ritu Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2019 | 44 | |
| 10 | 2018 | 36 | |
| 11 | 2017 | 29 | |
| 12 | 2016 | 21 | |
| 13 | 2013 | 52 | |
| 14 | 2012 | 78 | |
| 15 | 2012 | 30 | |
| 16 | 2011 | 55 | |
| 17 | 2011 | 88 | |
| 18 | 2010 | 30 | |
| 19 | 2009 | 25 | |
| 20 | 2009 | 96 |
About Ritu Roy
Ritu Roy is a scholar working on Cancer Research, Genetics and Oncology, having authored 64 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Epigenetics and DNA Methylation (11 papers), Glioma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (7 papers), Genomic variations and chromosomal abnormalities (6 papers), RNA modifications and cancer (6 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related cognitive impairment studies (5 papers). The work is most often cited by research in Ophthalmology (699 citations), Cancer Research (665 citations) and Oncology (1.1k citations). Ritu Roy has collaborated with scholars based in United States, South Korea and Australia. Frequent co-authors include Boris C. Bastian, Klaus J. Busam, Klaus Griewank, Michael R. Speicher, Mert Sozen, Michelle B. Crosby, Igor Dolgalev, Catherine D. Van Raamsdonk, Nancy Bouvier and Adriana Heguy. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Supportive Care in Cancer, Journal of Clinical Oncology and Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.